Drug search by name

Ofatumumab Intravenous and Cardiopulmonary disease

Result of checking the interaction of drug Ofatumumab Intravenous and disease Cardiopulmonary disease for safety when used together.

Check result:

Ofatumumab Intravenous <> Cardiopulmonary disease

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Patients with a prior history of cardiac or pulmonary disease should be closely monitored during and after the infusion of anti-CD20 antibodies as they can increase the risk of presenting a severe and life-threatening infusion reaction. Therapy with these agents should be permanently discontinued in patients presenting any Grade 4 infusion reactions and for those presenting Grade 3, interrupt therapy and institute treatment according to clinical guidelines. The rate of infusion should be reduced for those patients presenting Grade 1, or 2 reactions.

Ofatumumab Intravenous

Generic Name: ofatumumab

Brand Name: Arzerra

Synonyms: Ofatumumab

What is Ofatumumab Intravenous?